Thoracoabdominal aortic replacement in patients aged 50 and younger.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 30 01 2018
accepted: 19 03 2018
pubmed: 4 4 2018
medline: 21 3 2019
entrez: 4 4 2018
Statut: ppublish

Résumé

Open repair of a thoracoabdominal aortic aneurysm (TAAA) has been regarded as one of the most invasive procedures in cardiovascular surgery. Conversely, endovascular technology currently enables the repair of the thoracoabdominal aorta, and this approach is less invasive. However, the long-term durability of this method of endovascular repair remains unknown. This investigation retrospectively analyzed the long-term durability of thoracoabdominal aorta repair in patients aged 50 and younger. Since 1995, 100 patients aged 50 and younger underwent thoracoabdominal aortic replacement at our institution. There were 63 males, and the average age was 38 ± 7. Ninety-six had aortic dissection as an aortic pathology. Marfan syndrome was found in 61 patients, Loeys-Dietz in 10, Acta 2 mutations in 4, aortitis in 2, and Ehlers-Danlos syndrome in 1. There were 2 patients with a type I TAAA, 56 with a type II, 33 with a type III, and 9 with a type IV. There were 3 hospital deaths (3%), of which 2 were emergent cases. Spinal cord injury occurred in 1 patient (1%). Two patients (2%) had wound complications. Three patients suffered cerebral hemorrhage and 1 had an intramedullary infection, of which all were associated with cerebrospinal fluid drainage. The 3-year survival rate after the operation was 94%, that of 5 years was 94%, and that of 10 years was 91%. Results of thoracoabdominal aortic replacement in patients aged 50 and younger were favorable. While spinal cord complications were rare, cerebrospinal drainage revealed several complications in this series. Evolving endovascular repair needs to be compared with these results, especially in patients aged 50 and younger.

Identifiants

pubmed: 29611032
doi: 10.1007/s11748-018-0917-y
pii: 10.1007/s11748-018-0917-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-58

Références

J Am Coll Cardiol. 2010 Apr 6;55(14):e27-e129
pubmed: 20359588
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1464-72
pubmed: 20494193
Ann Thorac Surg. 2013 Jan;95(1):12-9; discussion 19
pubmed: 22785215
Ann Thorac Surg. 2012 Sep;94(3):759-65
pubmed: 22818967
Ann Thorac Surg. 2013 Feb;95(2):737-49
pubmed: 23273625
Ann Cardiothorac Surg. 2012 Sep;1(3):286-92
pubmed: 23977510
Interact Cardiovasc Thorac Surg. 2014 Aug;19(2):205-10
pubmed: 24827461
Eur Heart J. 2014 Nov 1;35(41):2873-926
pubmed: 25173340
J Cardiothorac Vasc Anesth. 2015 Apr;29(2):342-50
pubmed: 25440632
J Cardiothorac Surg. 2014 Dec 10;9:195
pubmed: 25491157
Gen Thorac Cardiovasc Surg. 2016 Jan;64(1):55-7
pubmed: 26467802
Ann Thorac Surg. 2016 Jun;101(6):2193-201
pubmed: 26876340
J Thorac Cardiovasc Surg. 2016 May;151(5):1323-37
pubmed: 26898979
Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):367-70
pubmed: 27209533
Biomed Res Int. 2017;2017:7268521
pubmed: 28116311
J Vasc Surg. 2017 Nov;66(5):1406-1416
pubmed: 28648480
Eur J Vasc Endovasc Surg. 2017 Nov;54(5):588-596
pubmed: 28916127

Auteurs

Kenji Minatoya (K)

Kyoto University Hospital, Kyoto, Japan. minatoya@kuhp.kyoto-u.ac.jp.

Yosuke Inoue (Y)

National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshimasa Seike (Y)

National Cerebral and Cardiovascular Center, Suita, Japan.

Atsushi Omura (A)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kyokun Uehara (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Hiroaki Sasaki (H)

National Cerebral and Cardiovascular Center, Suita, Japan.

Hitoshi Matsuda (H)

National Cerebral and Cardiovascular Center, Suita, Japan.

Junjiro Kobayashi (J)

National Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH